{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:27:12Z","timestamp":1794536832499,"version":"4.9.1"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01015-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:04:47Z","timestamp":1751378687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Patient, target, device, and program selection for DBS in Parkinson\u2019s disease: advancing toward precision care"],"prefix":"10.1038","volume":"11","author":[{"given":"Aparna","family":"Wagle Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5247-8810","authenticated-orcid":false,"given":"Manuel","family":"Bange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuraman","family":"Muthuraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1015_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(12)70049-2","volume":"11","author":"A Fasano","year":"2012","unstructured":"Fasano, A., Daniele, A. & Albanese, A. Treatment of motor and non-motor features of Parkinson\u2019s disease with deep brain stimulation. Lancet Neurol. 11, 429\u2013442 (2012).","journal-title":"Lancet Neurol."},{"key":"1015_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13311-013-0235-0","volume":"11","author":"A Wagle Shukla","year":"2014","unstructured":"Wagle Shukla, A. & Okun, M. S. Surgical treatment of Parkinson\u2019s disease: patients, targets, devices, and approaches. Neurotherapeutics 11, 47\u201359 (2014).","journal-title":"Neurotherapeutics"},{"key":"1015_CR3","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1111\/ene.15386","volume":"29","author":"G Deuschl","year":"2022","unstructured":"Deuschl, G. et al. European Academy of Neurology\/Movement Disorder Society\u2014European Section guideline on the treatment of Parkinson\u2019s disease: I. Invasive therapies. Eur. J. Neurol. 29, 2580\u20132595 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1015_CR4","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1080\/03007995.2018.1502165","volume":"34","author":"A Antonini","year":"2018","unstructured":"Antonini, A. et al. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson\u2019s disease: a multi-country Delphi-panel approach. Curr. Med. Res. Opin. 34, 2063\u20132073 (2018).","journal-title":"Curr. Med. Res. Opin."},{"key":"1015_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/14737175.2018.1535902","volume":"18","author":"J Siddiqui","year":"2018","unstructured":"Siddiqui, J. et al. Rationale and patient selection for interventional therapies in Parkinson\u2019s disease. Expert Rev. Neurother. 18, 811\u2013823 (2018).","journal-title":"Expert Rev. Neurother."},{"key":"1015_CR6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00702-023-02668-9","volume":"130","author":"M Auffret","year":"2023","unstructured":"Auffret, M., Weiss, D., Stocchi, F., V\u00e9rin, M. & Jost, W. H. Access to device-aided therapies in advanced Parkinson\u2019s disease: navigating clinician biases, patient preference, and prognostic uncertainty. J. Neural Transm. (Vienna) 130, 1411\u20131432 (2023).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1015_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl, G. et al. A randomized trial of deep-brain stimulation for Parkinson\u2019s disease. N. Engl. J. Med. 355, 896\u2013908 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1015_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2008.929","volume":"301","author":"FM Weaver","year":"2009","unstructured":"Weaver, F. M. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301, 63\u201373 (2009).","journal-title":"JAMA"},{"key":"1015_CR9","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1056\/NEJMoa0907083","volume":"362","author":"KA Follett","year":"2010","unstructured":"Follett, K. A. et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson\u2019s disease. N. Engl. J. Med. 362, 2077\u20132091 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1015_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1474-4422(10)70093-4","volume":"9","author":"A Williams","year":"2010","unstructured":"Williams, A. et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson\u2019s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 9, 581\u2013591 (2010).","journal-title":"Lancet Neurol."},{"key":"1015_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(11)70308-8","volume":"11","author":"MS Okun","year":"2012","unstructured":"Okun, M. S. et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson\u2019s disease: an open-label randomised controlled trial. Lancet Neurol. 11, 140\u2013149 (2012).","journal-title":"Lancet Neurol."},{"key":"1015_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1474-4422(12)70264-8","volume":"12","author":"VJ Odekerken","year":"2013","unstructured":"Odekerken, V. J. et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson\u2019s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 12, 37\u201344 (2013).","journal-title":"Lancet Neurol."},{"key":"1015_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1205158","volume":"368","author":"WM Schuepbach","year":"2013","unstructured":"Schuepbach, W. M. et al. Neurostimulation for Parkinson\u2019s disease with early motor complications. N. Engl. J. Med. 368, 610\u2013622 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1015_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1474-4422(20)30108-3","volume":"19","author":"JL Vitek","year":"2020","unstructured":"Vitek, J. L. et al. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson\u2019s disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. Lancet Neurol. 19, 491\u2013501 (2020).","journal-title":"Lancet Neurol."},{"key":"1015_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1109\/RBME.2016.2588399","volume":"9","author":"A Wagle Shukla","year":"2016","unstructured":"Wagle Shukla, A. & Okun, M. S. State of the art for deep brain stimulation therapy in movement disorders: a clinical and technological perspective. IEEE Rev. Biomed. Eng. 9, 219\u2013233 (2016).","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"1015_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.21547","volume":"22","author":"F Ory-Magne","year":"2007","unstructured":"Ory-Magne, F. et al. Does ageing influence deep brain stimulation outcomes in Parkinson\u2019s disease?. Mov. Disord. 22, 1457\u20131463 (2007).","journal-title":"Mov. Disord."},{"key":"1015_CR17","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/cns.13958","volume":"28","author":"T Du","year":"2022","unstructured":"Du, T. et al. The effect of age and disease duration on the efficacy of subthalamic nuclei deep brain stimulation in Parkinson\u2019s disease patients. CNS Neurosci. Ther. 28, 2163\u20132171 (2022).","journal-title":"CNS Neurosci. Ther."},{"key":"1015_CR18","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1001\/jamaneurol.2014.1272","volume":"71","author":"MR DeLong","year":"2014","unstructured":"DeLong, M. R. et al. Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease. JAMA Neurol. 71, 1290\u20131295 (2014).","journal-title":"JAMA Neurol."},{"key":"1015_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.parkreldis.2019.10.019","volume":"69","author":"DS Abraham","year":"2019","unstructured":"Abraham, D. S. et al. Sex differences in Parkinson\u2019s disease presentation and progression. Parkinsonism Relat. Disord. 69, 48\u201354 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/mds.28921","volume":"37","author":"I Subramanian","year":"2022","unstructured":"Subramanian, I. et al. Unmet needs of women living with parkinson\u2019s disease: gaps and controversies. Mov. Disord. 37, 444\u2013455 (2022).","journal-title":"Mov. Disord."},{"key":"1015_CR21","doi-asserted-by":"crossref","unstructured":"Dalrymple, W. A. et al. Comparison of Parkinson\u2019s disease patients\u2019 characteristics by indication for deep brain stimulation: men are more likely to have DBS for tremor. Tremor Other Hyperkinet Mov (N Y) 9 (2019).","DOI":"10.5334\/tohm.468"},{"key":"1015_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1429251","volume":"15","author":"G Maccarrone","year":"2024","unstructured":"Maccarrone, G. et al. Gender disparity in access to advanced therapies for patients with Parkinson\u2019s disease: a retrospective real-word study. Front. Neurol. 15, 1429251 (2024).","journal-title":"Front. Neurol."},{"key":"1015_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41531-022-00305-y","volume":"8","author":"ST Jost","year":"2022","unstructured":"Jost, S. T. et al. Gender gap in deep brain stimulation for Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 47 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1015_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1212\/WNL.0000000000000017","volume":"82","author":"AW Willis","year":"2014","unstructured":"Willis, A. W. et al. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology 82, 163\u2013171 (2014).","journal-title":"Neurology"},{"key":"1015_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/ner.12973","volume":"22","author":"DS Shpiner","year":"2019","unstructured":"Shpiner, D. S. et al. Gender disparities in deep brain stimulation for Parkinson\u2019s disease. Neuromodulation 22, 484\u2013488 (2019).","journal-title":"Neuromodulation"},{"key":"1015_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107322","volume":"133","author":"J Jimenez-Shahed","year":"2025","unstructured":"Jimenez-Shahed, J. et al. Association of patient characteristics, social drivers of health, and geographic location on access to device-aided therapies among medicare beneficiaries with advanced Parkinson\u2019s disease. Parkinsonism Relat. Disord. 133, 107322 (2025).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1257781","volume":"14","author":"M Hendriks","year":"2023","unstructured":"Hendriks, M., Vinke, R. S. & Georgiev, D. Gender discrepancies and differences in motor and non-motor symptoms, cognition, and psychological outcomes in the treatment of Parkinson\u2019s disease with subthalamic deep brain stimulation. Front. Neurol. 14, 1257781 (2023).","journal-title":"Front. Neurol."},{"key":"1015_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1269401","volume":"17","author":"AA Memon","year":"2023","unstructured":"Memon, A. A. et al. A systematic review of health disparities research in deep brain stimulation surgery for Parkinson\u2019s disease. Front. Hum. Neurosci. 17, 1269401 (2023).","journal-title":"Front. Hum. Neurosci."},{"key":"1015_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3171\/2023.11.JNS23882","volume":"141","author":"V Venkatraman","year":"2024","unstructured":"Venkatraman, V. et al. Disparities in the treatment of movement disorders using deep brain stimulation. J. Neurosurg. 141, 241\u2013251 (2024).","journal-title":"J. Neurosurg."},{"key":"1015_CR30","doi-asserted-by":"publisher","unstructured":"Currie, A. D. et al. The role of a social worker in the deep brain stimulation preoperative evaluation: the DBS-FACTS screening tool. Mov. Disord. Clin. Pract. https:\/\/doi.org\/10.1002\/mdc3.70026 (2025).","DOI":"10.1002\/mdc3.70026"},{"key":"1015_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C","volume":"14","author":"GL Defer","year":"1999","unstructured":"Defer, G. L., Widner, H., Mari\u00e9, R. M., R\u00e9my, P. & Levivier, M. Core assessment program for surgical interventional therapies in Parkinson\u2019s disease (CAPSIT-PD). Mov. Disord. 14, 572\u2013584 (1999).","journal-title":"Mov. Disord."},{"key":"1015_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/mds.10123","volume":"17","author":"M Merello","year":"2002","unstructured":"Merello, M., Nouzeilles, M. I., Arce, G. P. & Leiguarda, R. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson\u2019s disease diagnosis. Mov. Disord. 17, 795\u2013798 (2002).","journal-title":"Mov. Disord."},{"key":"1015_CR33","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3171\/2018.12.JNS182042","volume":"132","author":"G Deuschl","year":"2019","unstructured":"Deuschl, G. et al. Comparing two randomized deep brain stimulation trials for Parkinson\u2019s disease. J. Neurosurg. 132, 1376\u20131384 (2019).","journal-title":"J. Neurosurg."},{"key":"1015_CR34","doi-asserted-by":"publisher","first-page":"S290","DOI":"10.1002\/mds.20962","volume":"21","author":"G Kleiner-Fisman","year":"2006","unstructured":"Kleiner-Fisman, G. et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. 21, S290\u2013S304 (2006).","journal-title":"Mov. Disord."},{"key":"1015_CR35","doi-asserted-by":"crossref","unstructured":"Artusi, C. A., Lopiano, L. & Morgante, F. Deep brain stimulation selection criteria for parkinson\u2019s disease: time to go beyond CAPSIT-PD. J. Clin. Med. 9 (2020).","DOI":"10.3390\/jcm9123931"},{"key":"1015_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nrneurol.2014.252","volume":"11","author":"A Fasano","year":"2015","unstructured":"Fasano, A., Aquino, C. C., Krauss, J. K., Honey, C. R. & Bloem, B. R. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat. Rev. Neurol. 11, 98\u2013110 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"1015_CR37","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/mdc3.13825","volume":"10","author":"R Wolke","year":"2023","unstructured":"Wolke, R. et al. The role of Levodopa challenge in predicting the outcome of subthalamic deep brain stimulation. Mov. Disord. Clin. Pr. 10, 1181\u20131191 (2023).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1015_CR38","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ana.26961","volume":"96","author":"A Zampogna","year":"2024","unstructured":"Zampogna, A. et al. Disentangling Bradykinesia and rigidity in Parkinson\u2019s disease: evidence from short- and long-term subthalamic nucleus deep brain stimulation. Ann. Neurol. 96, 234\u2013246 (2024).","journal-title":"Ann. Neurol."},{"key":"1015_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1179\/1743132811Y.0000000044","volume":"33","author":"MS Bryant","year":"2011","unstructured":"Bryant, M. S. et al. Gait variability in Parkinson\u2019s disease: influence of walking speed and dopaminergic treatment. Neurol. Res. 33, 959\u2013964 (2011).","journal-title":"Neurol. Res."},{"key":"1015_CR40","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3171\/2018.8.JNS18350","volume":"131","author":"R Kim","year":"2019","unstructured":"Kim, R. et al. Long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson\u2019s disease. J. Neurosurg. 131, 1797\u20131804 (2019).","journal-title":"J. Neurosurg."},{"key":"1015_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mds.27892","volume":"35","author":"MT Barbe","year":"2020","unstructured":"Barbe, M. T. et al. Deep Brain Stimulation for Freezing of Gait in Parkinson\u2019s Disease With Early Motor Complications. Mov. Disord. 35, 82\u201390 (2020).","journal-title":"Mov. Disord."},{"key":"1015_CR42","doi-asserted-by":"crossref","unstructured":"Di Rauso, G. et al. Freezing of gait in Parkinson\u2019s disease patients treated with bilateral subthalamic nucleus deep brain stimulation: a long-term overview. Biomedicines 10 (2022).","DOI":"10.3390\/biomedicines10092214"},{"key":"1015_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/ane.12889","volume":"137","author":"CA Artusi","year":"2018","unstructured":"Artusi, C. A. et al. Subthalamic deep brain stimulation and trunk posture in Parkinson\u2019s disease. Acta Neurol. Scand. 137, 481\u2013487 (2018).","journal-title":"Acta Neurol. Scand."},{"key":"1015_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.parkreldis.2019.01.003","volume":"62","author":"J Roediger","year":"2019","unstructured":"Roediger, J. et al. Effect of subthalamic deep brain stimulation on posture in Parkinson\u2019s disease: A blind computerized analysis. Parkinsonism Relat. Disord. 62, 122\u2013127 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR45","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s00415-017-8424-0","volume":"264","author":"AL Silva de Lima","year":"2017","unstructured":"Silva de Lima, A. L. et al. Freezing of gait and fall detection in Parkinson\u2019s disease using wearable sensors: a systematic review. J. Neurol. 264, 1642\u20131654 (2017).","journal-title":"J. Neurol."},{"key":"1015_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41531-022-00383-y","volume":"8","author":"A Zampogna","year":"2022","unstructured":"Zampogna, A. et al. Axial impairment and falls in Parkinson\u2019s disease: 15 years of subthalamic deep brain stimulation. NPJ Parkinsons Dis. 8, 121 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1015_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38555-2","volume":"13","author":"A Gessani","year":"2023","unstructured":"Gessani, A. et al. Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson\u2019s disease. Sci. Rep. 13, 11462 (2023).","journal-title":"Sci. Rep."},{"key":"1015_CR48","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3233\/JPD-202246","volume":"10","author":"SY Chiu","year":"2020","unstructured":"Chiu, S. Y. et al. Dysarthria and speech intelligibility following parkinson\u2019s disease globus pallidus internus deep brain stimulation. J. Parkinsons Dis. 10, 1493\u20131502 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1015_CR49","doi-asserted-by":"publisher","first-page":"e0302739","DOI":"10.1371\/journal.pone.0302739","volume":"19","author":"F Tabari","year":"2024","unstructured":"Tabari, F. et al. Speech, voice, and language outcomes following deep brain stimulation: a systematic review. PLoS ONE 19, e0302739 (2024).","journal-title":"PLoS ONE"},{"key":"1015_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ibneur.2024.01.015","volume":"16","author":"F van Brenk","year":"2024","unstructured":"van Brenk, F. et al. No differential effects of subthalamic nucleus vs. globus pallidus deep brain stimulation in Parkinson\u2019s disease: Speech acoustic and perceptual findings. IBRO Neurosci. Rep. 16, 361\u2013367 (2024).","journal-title":"IBRO Neurosci. Rep."},{"key":"1015_CR51","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s10072-016-2681-z","volume":"37","author":"AP Diaz","year":"2016","unstructured":"Diaz, A. P. et al. Variables associated with physical health-related quality of life in Parkinson\u2019s disease patients presenting for deep brain stimulation. Neurol. Sci. 37, 1831\u20131837 (2016).","journal-title":"Neurol. Sci."},{"key":"1015_CR52","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mds.27283","volume":"33","author":"HS Dafsari","year":"2018","unstructured":"Dafsari, H. S. et al. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson\u2019s disease. Mov. Disord. 33, 421\u2013430 (2018).","journal-title":"Mov. Disord."},{"key":"1015_CR53","doi-asserted-by":"crossref","unstructured":"Gronostay, A. et al. Stratifying quality of life outcome in subthalamic stimulation for Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry (2023).","DOI":"10.1136\/jnnp-2023-332272"},{"key":"1015_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/ene.14147","volume":"27","author":"VJ Geraedts","year":"2020","unstructured":"Geraedts, V. J., Feleus, S., Marinus, J., van Hilten, J. J. & Contarino, M. F. What predicts quality of life after subthalamic deep brain stimulation in Parkinson\u2019s disease? A systematic review. Eur. J. Neurol. 27, 419\u2013428 (2020).","journal-title":"Eur. J. Neurol."},{"key":"1015_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000480910","volume":"33","author":"S Paschen","year":"2018","unstructured":"Paschen, S. & Deuschl, G. Patient evaluation and selection for movement disorders surgery: the changing spectrum of indications. Prog. Neurol. Surg. 33, 80\u201393 (2018).","journal-title":"Prog. Neurol. Surg."},{"key":"1015_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1474-4422(18)30035-8","volume":"17","author":"E Lhommee","year":"2018","unstructured":"Lhommee, E. et al. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson\u2019s disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. Lancet Neurol. 17, 223\u2013231 (2018).","journal-title":"Lancet Neurol."},{"key":"1015_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/mds.27588","volume":"34","author":"L Ricciardi","year":"2019","unstructured":"Ricciardi, L., Sorbera, C., Barbuto, M. & Morgante, F. Sleep disturbances are mainly improved by deep brain stimulation of the subthalamic nucleus. Mov. Disord. 34, 154\u2013155 (2019).","journal-title":"Mov. Disord."},{"key":"1015_CR58","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/jnnp-2019-322614","volume":"91","author":"ST Jost","year":"2020","unstructured":"Jost, S. T. et al. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson\u2019s disease: results at the 36-month follow-up. J. Neurol. Neurosurg. Psychiatry 91, 687\u2013694 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1015_CR59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.parkreldis.2019.07.011","volume":"66","author":"VJ Geraedts","year":"2019","unstructured":"Geraedts, V. J. et al. Selecting candidates for Deep Brain Stimulation in Parkinson\u2019s disease: the role of patients\u2019 expectations. Parkinsonism Relat. Disord. 66, 207\u2013211 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR60","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1007\/s00415-023-11898-6","volume":"270","author":"F Mameli","year":"2023","unstructured":"Mameli, F. et al. Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson\u2019s disease: a systematic review. J. Neurol. 270, 5274\u20135287 (2023).","journal-title":"J. Neurol."},{"key":"1015_CR61","doi-asserted-by":"publisher","first-page":"e187800","DOI":"10.1001\/jamanetworkopen.2018.7800","volume":"2","author":"CA Artusi","year":"2019","unstructured":"Artusi, C. A. et al. Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic parkinson disease: a systematic review and meta-analysis. JAMA Netw. Open 2, e187800 (2019).","journal-title":"JAMA Netw. Open"},{"key":"1015_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/mdc3.12795","volume":"6","author":"LM De Oliveira","year":"2019","unstructured":"De Oliveira, L. M. et al. Deep brain stimulation in patients with mutations in Parkinson\u2019s disease-related genes: a systematic review. Mov. Disord. Clin. Pr. 6, 359\u2013368 (2019).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1015_CR63","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00415-019-09181-8","volume":"267","author":"T Kuusim\u00e4ki","year":"2020","unstructured":"Kuusim\u00e4ki, T. et al. Deep brain stimulation for monogenic Parkinson\u2019s disease: a systematic review. J. Neurol. 267, 883\u2013897 (2020).","journal-title":"J. Neurol."},{"key":"1015_CR64","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1227\/01.neu.0000318171.82719.35","volume":"62","author":"JC G\u00f3mez-Esteban","year":"2008","unstructured":"G\u00f3mez-Esteban, J. C. et al. Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene. Neurosurgery 62, 857\u2013862 (2008).","journal-title":"Neurosurgery"},{"key":"1015_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2020.04.002","volume":"76","author":"G Mangone","year":"2020","unstructured":"Mangone, G. et al. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson\u2019s disease patients with GBA mutations. Parkinsonism Relat. Disord. 76, 56\u201362 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR66","first-page":"309","volume":"95","author":"M Avenali","year":"2024","unstructured":"Avenali, M. et al. Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort. J. Neurol. Neurosurg. Psychiatry 95, 309\u2013315 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1015_CR67","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.24777","volume":"80","author":"R Cilia","year":"2016","unstructured":"Cilia, R. et al. Survival and dementia in GBA-associated Parkinson\u2019s disease: the mutation matters. Ann. Neurol. 80, 662\u2013673 (2016).","journal-title":"Ann. Neurol."},{"key":"1015_CR68","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.26302","volume":"91","author":"G Pal","year":"2022","unstructured":"Pal, G. et al. Parkinson disease and subthalamic nucleus deep brain stimulation: cognitive effects in GBA mutation carriers. Ann. Neurol. 91, 424\u2013435 (2022).","journal-title":"Ann. Neurol."},{"key":"1015_CR69","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/mds.21903","volume":"23","author":"E Lohmann","year":"2008","unstructured":"Lohmann, E. et al. Are Parkinson's patients particularly suited for deep-brain stimulation?. Mov. Disord. 23, 740\u2013743 (2008).","journal-title":"Mov. Disord."},{"key":"1015_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jocn.2013.03.026","volume":"21","author":"HJ Kim","year":"2014","unstructured":"Kim, H. J. et al. Parkin mutation and deep brain stimulation outcome. J. Clin. Neurosci. 21, 107\u2013110 (2014).","journal-title":"J. Clin. Neurosci."},{"key":"1015_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105282","volume":"107","author":"P Prendes Fern\u00e1ndez","year":"2023","unstructured":"Prendes Fern\u00e1ndez, P. et al. Analysis of deep brain stimulation of the subthalamic nucleus (STN-DBS) in patients with monogenic PRKN and LRRK2 forms of Parkinson\u2019s disease. Parkinsonism Relat. Disord. 107, 105282 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR72","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1212\/WNL.0000000000005829","volume":"91","author":"LY Cabrera","year":"2018","unstructured":"Cabrera, L. Y., Goudreau, J. & Sidiropoulos, C. Critical appraisal of the recent US FDA approval for earlier DBS intervention. Neurology 91, 133\u2013136 (2018).","journal-title":"Neurology"},{"key":"1015_CR73","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/mds.26024","volume":"29","author":"TA Mestre","year":"2014","unstructured":"Mestre, T. A. et al. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson\u2019s disease-the EARLYSTIM trial: early is not always better. Mov. Disord. 29, 1751\u20131756 (2014).","journal-title":"Mov. Disord."},{"key":"1015_CR74","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/mds.26080","volume":"29","author":"WM Schupbach","year":"2014","unstructured":"Schupbach, W. M. et al. Myths and facts about the EARLYSTIM study. Mov. Disord. 29, 1742\u20131750 (2014).","journal-title":"Mov. Disord."},{"key":"1015_CR75","first-page":"175","volume":"149","author":"P Pollak","year":"1993","unstructured":"Pollak, P. et al. [Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev. Neurol. (Paris) 149, 175\u2013176 (1993).","journal-title":"Rev. Neurol. (Paris)"},{"key":"1015_CR76","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.parkreldis.2010.04.005","volume":"16","author":"P Blomstedt","year":"2010","unstructured":"Blomstedt, P. & Hariz, M. I. Deep brain stimulation for movement disorders before DBS for movement disorders. Parkinsonism Relat. Disord. 16, 429\u2013433 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR77","doi-asserted-by":"crossref","unstructured":"Siegfried, J. & Lippitz, B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35, 1126\u20131129.","DOI":"10.1097\/00006123-199412000-00016"},{"key":"1015_CR78","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","volume":"339","author":"P Limousin","year":"1998","unstructured":"Limousin, P. et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. N. Engl. J. Med. 339, 1105\u20131111 (1998).","journal-title":"N. Engl. J. Med."},{"key":"1015_CR79","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1212\/WNL.0000000000002401","volume":"86","author":"VJ Odekerken","year":"2016","unstructured":"Odekerken, V. J. et al. GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up. Neurology 86, 755\u2013761 (2016).","journal-title":"Neurology"},{"key":"1015_CR80","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1002\/mds.10163","volume":"17","author":"P Krack","year":"2002","unstructured":"Krack, P., Fraix, V., Mendes, A., Benabid, A. L. & Pollak, P. Postoperative management of subthalamic nucleus stimulation for Parkinson\u2019s disease. Mov. Disord. 17, S188\u2013S197 (2002).","journal-title":"Mov. Disord."},{"key":"1015_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JPD-225060","volume":"13","author":"W Pirker","year":"2023","unstructured":"Pirker, W., Katzenschlager, R., Hallett, M. & Poewe, W. Pharmacological treatment of tremor in Parkinson\u2019s disease revisited. J. Parkinsons Dis. 13, 127\u2013144 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"1015_CR82","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2018.08.017","volume":"58","author":"JK Wong","year":"2019","unstructured":"Wong, J. K. et al. STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: a systematic review and meta-analysis. Parkinsonism Relat. Disord. 58, 56\u201362 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2020.578615","volume":"14","author":"JK Wong","year":"2020","unstructured":"Wong, J. K. et al. STN versus GPi deep brain stimulation for action and rest tremor in Parkinson\u2019s disease. Front. Hum. Neurosci. 14, 578615 (2020).","journal-title":"Front. Hum. Neurosci."},{"key":"1015_CR84","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1212\/WNL.0000000000004295","volume":"89","author":"RG Cury","year":"2017","unstructured":"Cury, R. G. et al. Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia. Neurology 89, 1416\u20131423 (2017).","journal-title":"Neurology"},{"key":"1015_CR85","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3171\/2021.4.JNS21502","volume":"136","author":"A Azghadi","year":"2022","unstructured":"Azghadi, A., Rajagopal, M. M., Atkinson, K. A. & Holloway, K. L. Utility of GPI+VIM dual-lead deep brain stimulation for Parkinson\u2019s disease patients with significant residual tremor on medication. J. Neurosurg. 136, 1364\u20131370 (2022).","journal-title":"J. Neurosurg."},{"key":"1015_CR86","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40035-015-0034-0","volume":"4","author":"D Martinez-Ramirez","year":"2015","unstructured":"Martinez-Ramirez, D., Hu, W., Bona, A. R., Okun, M. S. & Wagle Shukla, A. Update on deep brain stimulation in Parkinson\u2019s disease. Transl. Neurodegener. 4, 12 (2015).","journal-title":"Transl. Neurodegener."},{"key":"1015_CR87","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.parkreldis.2012.05.024","volume":"18","author":"P Blomstedt","year":"2012","unstructured":"Blomstedt, P. et al. Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor. Parkinsonism Relat. Disord. 18, 1062\u20131066 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/cjn.2016.22","volume":"44","author":"CR Honey","year":"2017","unstructured":"Honey, C. R. et al. Deep brain stimulation target selection for Parkinson\u2019s disease. Can. J. Neurol. Sci. 44, 3\u20138 (2017).","journal-title":"Can. J. Neurol. Sci."},{"key":"1015_CR89","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10072-023-06999-z","volume":"45","author":"M Mainardi","year":"2024","unstructured":"Mainardi, M. et al. Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson\u2019s disease: a multicenter, retrospective study of efficacy and safety. Neurol. Sci. 45, 177\u2013185 (2024).","journal-title":"Neurol. Sci."},{"key":"1015_CR90","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41531-021-00276-6","volume":"8","author":"RG Cury","year":"2022","unstructured":"Cury, R. G., Pavese, N., Aziz, T. Z., Krauss, J. K. & Moro, E. Gaps and roadmap of novel neuromodulation targets for treatment of gait in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 8 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1015_CR91","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mds.27098","volume":"33","author":"W Thevathasan","year":"2018","unstructured":"Thevathasan, W. et al. Pedunculopontine nucleus deep brain stimulation in Parkinson\u2019s disease: a clinical review. Mov. Disord. 33, 10\u201320 (2018).","journal-title":"Mov. Disord."},{"key":"1015_CR92","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1080\/02688690802448426","volume":"22","author":"L Zrinzo","year":"2008","unstructured":"Zrinzo, L. & Zrinzo, L. V. Surgical anatomy of the pedunculopontine and peripeduncular nuclei. Br. J. Neurosurg. 22, S19\u2013S24 (2008).","journal-title":"Br. J. Neurosurg."},{"key":"1015_CR93","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1227\/NEU.0b013e31822b6f71","volume":"69","author":"W Thevathasan","year":"2011","unstructured":"Thevathasan, W. et al. Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery 69, 1248\u20131253 (2011).","journal-title":"Neurosurgery"},{"key":"1015_CR94","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00415-015-7744-1","volume":"262","author":"ML Welter","year":"2015","unstructured":"Welter, M. L. et al. PPNa-DBS for gait and balance disorders in Parkinson\u2019s disease: a double-blind, randomised study. J. Neurol. 262, 1515\u20131525 (2015).","journal-title":"J. Neurol."},{"key":"1015_CR95","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1093\/brain\/awt122","volume":"136","author":"D Weiss","year":"2013","unstructured":"Weiss, D. et al. Nigral stimulation for resistant axial motor impairment in Parkinson\u2019s disease? A randomized controlled trial. Brain 136, 2098\u20132108 (2013).","journal-title":"Brain"},{"key":"1015_CR96","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.parkreldis.2018.09.008","volume":"60","author":"F Valldeoriola","year":"2019","unstructured":"Valldeoriola, F. et al. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson\u2019s disease: A pilot study. Parkinsonism Relat. Disord. 60, 153\u2013157 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jamaneurol.2017.3762","volume":"75","author":"J Gratwicke","year":"2018","unstructured":"Gratwicke, J. et al. Bilateral deep brain stimulation of the nucleus basalis of Meynert for Parkinson Disease Dementia: A Randomized Clinical Trial. JAMA Neurol. 75, 169\u2013178 (2018).","journal-title":"JAMA Neurol."},{"key":"1015_CR98","doi-asserted-by":"crossref","unstructured":"Bogdan I. D. et al. Serendipitous stimulation of nucleus basalis of Meynert\u2014the effect of unintentional, long-term high-frequency stimulation on cognition in Parkinson\u2019s disease. J Clin Med. 11. 2022","DOI":"10.3390\/jcm11020337"},{"key":"1015_CR99","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/mds.28870","volume":"37","author":"S Sasikumar","year":"2022","unstructured":"Sasikumar, S. et al. Single-trajectory multiple-target deep brain stimulation for parkinsonian mobility and cognition. Mov. Disord. 37, 635\u2013640 (2022).","journal-title":"Mov. Disord."},{"key":"1015_CR100","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/mdc3.13510","volume":"9","author":"D Cappon","year":"2022","unstructured":"Cappon, D. et al. Deep brain stimulation of the nucleus basalis of meynert for Parkinson\u2019s disease dementia: a 36\u2009months follow up study. Mov. Disord. Clin. Pr. 9, 765\u2013774 (2022).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1015_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.731109","volume":"15","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Predicting motor outcome of subthalamic nucleus deep brain stimulation for Parkinson\u2019s disease using quantitative susceptibility mapping and radiomics: a pilot study. Front. Neurosci. 15, 731109 (2021).","journal-title":"Front. Neurosci."},{"key":"1015_CR102","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/jnnp-2021-326710","volume":"93","author":"N Rijks","year":"2022","unstructured":"Rijks, N. et al. Combining 7T T2 and 3T FGATIR: from physiological to anatomical identification of the subthalamic nucleus borders. J. Neurol. Neurosurg. Psychiatry 93, 1019\u20131020 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1015_CR103","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuroimage.2018.05.048","volume":"178","author":"R Patriat","year":"2018","unstructured":"Patriat, R. et al. Individualized tractography-based parcellation of the globus pallidus pars interna using 7T MRI in movement disorder patients prior to DBS surgery. Neuroimage 178, 198\u2013209 (2018).","journal-title":"Neuroimage"},{"key":"1015_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1018017","volume":"14","author":"YC Shih","year":"2022","unstructured":"Shih, Y. C., Tseng, W. I. & Montaser-Kouhsari, L. Recent advances in using diffusion tensor imaging to study white matter alterations in Parkinson\u2019s disease: A mini review. Front Aging Neurosci. 14, 1018017 (2022).","journal-title":"Front Aging Neurosci."},{"key":"1015_CR105","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s40120-022-00331-1","volume":"11","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Mapping motor pathways in Parkinson\u2019s disease patients with subthalamic deep brain stimulator: a diffusion MRI tractography study. Neurol. Ther. 11, 659\u2013677 (2022).","journal-title":"Neurol. Ther."},{"key":"1015_CR106","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00415-023-12095-1","volume":"271","author":"D Deuter","year":"2024","unstructured":"Deuter, D. et al. Amelioration of Parkinsonian tremor evoked by DBS: which role play cerebello-(sub)thalamic fiber tracts?. J. Neurol. 271, 1451\u20131461 (2024).","journal-title":"J. Neurol."},{"key":"1015_CR107","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00701-020-04495-3","volume":"163","author":"A Abdulbaki","year":"2021","unstructured":"Abdulbaki, A., Kaufmann, J., Galazky, I., Buentjen, L. & Voges, J. Neuromodulation of the subthalamic nucleus in Parkinson\u2019s disease: the effect of fiber tract stimulation on tremor control. Acta Neurochir. (Wien.) 163, 185\u2013195 (2021).","journal-title":"Acta Neurochir. (Wien.)"},{"key":"1015_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2020.578348","volume":"14","author":"JD Jones","year":"2020","unstructured":"Jones, J. D. et al. Cognitive outcomes for essential tremor patients selected for thalamic deep brain stimulation surgery through interdisciplinary evaluations. Front Hum. Neurosci. 14, 578348 (2020).","journal-title":"Front Hum. Neurosci."},{"key":"1015_CR109","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000364913","volume":"92","author":"JA Thompson","year":"2014","unstructured":"Thompson, J. A., Lanctin, D., Ince, N. F. & Abosch, A. Clinical implications of local field potentials for understanding and treating movement disorders. Stereotact. Funct. Neurosurg. 92, 251\u2013263 (2014).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1015_CR110","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3171\/2017.12.JNS171964","volume":"130","author":"JA Thompson","year":"2018","unstructured":"Thompson, J. A. et al. Semi-automated application for estimating subthalamic nucleus boundaries and optimal target selection for deep brain stimulation implantation surgery. J. Neurosurg. 130, 1224\u20131233 (2018).","journal-title":"J. Neurosurg."},{"key":"1015_CR111","first-page":"324","volume":"142","author":"SF Maroufi","year":"2025","unstructured":"Maroufi, S. F. et al. Awake versus asleep deep brain stimulation for Parkinson\u2019s disease: a comprehensive systematic review and meta-analysis. J. Neurosurg. 142, 324\u2013338 (2025).","journal-title":"J. Neurosurg."},{"key":"1015_CR112","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1227\/neu.0000000000003138","volume":"96","author":"L Li","year":"2025","unstructured":"Li, L., Rae, A. I. & Burchiel, K. J. A meta-analysis of medication reduction and motor outcomes after awake versus asleep deep brain stimulation for Parkinson disease. Neurosurgery 96, 481\u2013493 (2025).","journal-title":"Neurosurgery"},{"key":"1015_CR113","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neurom.2024.04.002","volume":"28","author":"PH Huang","year":"2025","unstructured":"Huang, P. H., Pan, Y. S., Chen, S. Y. & Lin, S. H. Anesthetic effect on the subthalamic nucleus in microelectrode recording and local field potential of Parkinson\u2019s disease. Neuromodulation 28, 414\u2013424 (2025).","journal-title":"Neuromodulation"},{"key":"1015_CR114","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41582-020-00426-z","volume":"17","author":"JK Krauss","year":"2021","unstructured":"Krauss, J. K. et al. Technology of deep brain stimulation: current status and future directions. Nat. Rev. Neurol. 17, 75\u201387 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1015_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.708481","volume":"15","author":"C Sarica","year":"2021","unstructured":"Sarica, C. et al. Implantable pulse generators for deep brain stimulation: challenges, complications, and strategies for practicality and longevity. Front Hum. Neurosci. 15, 708481 (2021).","journal-title":"Front Hum. Neurosci."},{"key":"1015_CR116","doi-asserted-by":"crossref","unstructured":"Paff, M., Loh, A., Sarica, C., Lozano, A. M. & Fasano, A. Update on current technologies for deep brain stimulation in Parkinson\u2019s disease. J. Mov. Disord. 13, 185\u2013198 (2020).","DOI":"10.14802\/jmd.20052"},{"key":"1015_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.694747","volume":"12","author":"A Merola","year":"2021","unstructured":"Merola, A. et al. New frontiers for deep brain stimulation: directionality, sensing technologies, remote programming, robotic stereotactic assistance, asleep procedures, and connectomics. Front Neurol. 12, 694747 (2021).","journal-title":"Front Neurol."},{"key":"1015_CR118","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.parkreldis.2021.07.003","volume":"89","author":"D Soh","year":"2021","unstructured":"Soh, D. et al. Flexible vs. standard subthalamic stimulation in Parkinson disease: a double-blind proof-of-concept cross-over trial. Parkinsonism Relat. Disord. 89, 93\u201397 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR119","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.brs.2017.12.015","volume":"11","author":"P Rebelo","year":"2018","unstructured":"Rebelo, P. et al. Thalamic directional deep brain stimulation for tremor: spend less, get more. Brain Stimul. 11, 600\u2013606 (2018).","journal-title":"Brain Stimul."},{"key":"1015_CR120","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clinph.2022.05.004","volume":"140","author":"WJ Neumann","year":"2022","unstructured":"Neumann, W. J., K\u00f6hler, R. M. & K\u00fchn, A. A. A practical guide to invasive neurophysiology in patients with deep brain stimulation. Clin. Neurophysiol. 140, 171\u2013180 (2022).","journal-title":"Clin. Neurophysiol."},{"key":"1015_CR121","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3171\/2018.4.JNS172995","volume":"131","author":"FL Hitti","year":"2018","unstructured":"Hitti, F. L., Vaughan, K. A., Ramayya, A. G., McShane, B. J. & Baltuch, G. H. Reduced long-term cost and increased patient satisfaction with rechargeable implantable pulse generators for deep brain stimulation. J. Neurosurg. 131, 799\u2013806 (2018).","journal-title":"J. Neurosurg."},{"key":"1015_CR122","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000365576","volume":"92","author":"JF Thrane","year":"2014","unstructured":"Thrane, J. F., Sunde, N. A., Bergholt, B. & Rosendal, F. Increasing infection rate in multiple implanted pulse generator changes in movement disorder patients treated with deep brain stimulation. Stereotact. Funct. Neurosurg. 92, 360\u2013364 (2014).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1015_CR123","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000447521","volume":"94","author":"A Fytagoridis","year":"2016","unstructured":"Fytagoridis, A. et al. Surgical replacement of implantable pulse generators in deep brain stimulation: adverse events and risk factors in a multicenter cohort. Stereotact. Funct. Neurosurg. 94, 235\u2013239 (2016).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1015_CR124","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3171\/2019.5.JNS19360","volume":"133","author":"M Jakobs","year":"2020","unstructured":"Jakobs, M. et al. A multicenter, open-label, controlled trial on acceptance, convenience, and complications of rechargeable internal pulse generators for deep brain stimulation: the Multi Recharge Trial. J. Neurosurg. 133, 821\u2013829 (2020).","journal-title":"J. Neurosurg."},{"key":"1015_CR125","doi-asserted-by":"crossref","unstructured":"Jakobs, M. et al. A multicenter, open-label, controlled trial on acceptance, convenience, and complications of rechargeable internal pulse generators for deep brain stimulation: the Multi Recharge Trial. J. Neurosurg. 133, 821\u2013829 (2019).","DOI":"10.3171\/2019.5.JNS19360"},{"key":"1015_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.668322","volume":"12","author":"X Qiu","year":"2021","unstructured":"Qiu, X. et al. Fixed-life or rechargeable battery for deep brain stimulation: preference and satisfaction in Chinese patients with Parkinson\u2019s disease. Front Neurol. 12, 668322 (2021).","journal-title":"Front Neurol."},{"key":"1015_CR127","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000505076","volume":"97","author":"ME Wolf","year":"2019","unstructured":"Wolf, M. E. et al. Implementation of new technology in patients with chronic deep brain stimulation: switching from non-rechargeable constant voltage to rechargeable constant current stimulation. Stereotact. Funct. Neurosurg. 97, 362\u2013368 (2019).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1015_CR128","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/ner.12748","volume":"21","author":"M Jakobs","year":"2018","unstructured":"Jakobs, M., Klo\u00df, M., Unterberg, A. & Kiening, K. Rechargeable internal pulse generators as initial neurostimulators for deep brain stimulation in patients with movement disorders. Neuromodulation 21, 604\u2013610 (2018).","journal-title":"Neuromodulation"},{"key":"1015_CR129","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000444760","volume":"94","author":"S Falowski","year":"2016","unstructured":"Falowski, S., Safriel, Y., Ryan, M. P. & Hargens, L. The rate of magnetic resonance imaging in patients with deep brain stimulation. Stereotact. Funct. Neurosurg. 94, 147\u2013153 (2016).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1015_CR130","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.brs.2016.02.004","volume":"9","author":"M Picillo","year":"2016","unstructured":"Picillo, M., Lozano, A. M., Kou, N., Puppi Munhoz, R. & Fasano, A. Programming deep brain stimulation for Parkinson\u2019s disease: the Toronto Western Hospital Algorithms. Brain Stimul. 9, 425\u2013437 (2016).","journal-title":"Brain Stimul."},{"key":"1015_CR131","volume":"2017","author":"A Wagle Shukla","year":"2017","unstructured":"Wagle Shukla, A., Zeilman, P., Fernandez, H., Bajwa, J. A. & Mehanna, R. DBS Programming: an evolving approach for patients with Parkinson\u2019s disease. Parkinsons Dis. 2017, 8492619 (2017).","journal-title":"Parkinsons Dis."},{"key":"1015_CR132","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.parkreldis.2021.05.007","volume":"87","author":"M Fabbri","year":"2021","unstructured":"Fabbri, M. et al. Deep brain stimulation fine-tuning in Parkinson\u2019s disease: Short pulse width effect on speech. Parkinsonism Relat. Disord. 87, 130\u2013134 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR133","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/mds.28252","volume":"35","author":"V Dayal","year":"2020","unstructured":"Dayal, V. et al. Novel programming features help alleviate subthalamic nucleus stimulation-induced side effects. Mov. Disord. 35, 2261\u20132269 (2020).","journal-title":"Mov. Disord."},{"key":"1015_CR134","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/mds.27839","volume":"34","author":"CC Aquino","year":"2019","unstructured":"Aquino, C. C. et al. Interleaved deep brain stimulation for dyskinesia management in Parkinson\u2019s disease. Mov. Disord. 34, 1722\u20131727 (2019).","journal-title":"Mov. Disord."},{"key":"1015_CR135","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/17434440.2021.1962286","volume":"18","author":"B Patel","year":"2021","unstructured":"Patel, B. et al. Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technology. Expert Rev. Med Devices 18, 875\u2013891 (2021).","journal-title":"Expert Rev. Med Devices"},{"key":"1015_CR136","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/14737175.2023.2208749","volume":"23","author":"RP Munhoz","year":"2023","unstructured":"Munhoz, R. P. & Albuainain, G. Deep brain stimulation: new programming algorithms and teleprogramming. Expert Rev. Neurother. 23, 467\u2013478 (2023).","journal-title":"Expert Rev. Neurother."},{"key":"1015_CR137","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/mds.27093","volume":"32","author":"TA Dembek","year":"2017","unstructured":"Dembek, T. A. et al. Directional DBS increases side-effect thresholds\u2014A prospective, double-blind trial. Mov. Disord. 32, 1380\u20131388 (2017).","journal-title":"Mov. Disord."},{"key":"1015_CR138","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1212\/WNL.0000000000000823","volume":"83","author":"MF Contarino","year":"2014","unstructured":"Contarino, M. F. et al. Directional steering: a novel approach to deep brain stimulation. Neurology 83, 1163\u20131169 (2014).","journal-title":"Neurology"},{"key":"1015_CR139","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/brain\/awu102","volume":"137","author":"C Pollo","year":"2014","unstructured":"Pollo, C. et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain 137, 2015\u20132026 (2014).","journal-title":"Brain"},{"key":"1015_CR140","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/mds.26669","volume":"31","author":"F Steigerwald","year":"2016","unstructured":"Steigerwald, F., M\u00fcller, L., Johannes, S., Matthies, C. & Volkmann, J. Directional deep brain stimulation of the subthalamic nucleus: a pilot study using a novel neurostimulation device. Mov. Disord. 31, 1240\u20131243 (2016).","journal-title":"Mov. Disord."},{"key":"1015_CR141","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/ner.13407","volume":"25","author":"A Schnitzler","year":"2022","unstructured":"Schnitzler, A. et al. Directional deep brain stimulation for parkinson\u2019s disease: results of an international crossover study with randomized, double-blind primary endpoint. Neuromodulation 25, 817\u2013828 (2022).","journal-title":"Neuromodulation"},{"key":"1015_CR142","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1007\/s00701-023-05819-9","volume":"165","author":"PE Constanthin","year":"2023","unstructured":"Constanthin, P. E., Zemzemi, N., Cuny, E. & Engelhardt, J. Comparison of two segmentation software tools for deep brain stimulation of the subthalamic and ventro-intermedius nuclei. Acta Neurochir. (Wien.) 165, 3397\u20133402 (2023).","journal-title":"Acta Neurochir. (Wien.)"},{"key":"1015_CR143","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000375172","volume":"93","author":"MH Pourfar","year":"2015","unstructured":"Pourfar, M. H. et al. Model-based deep brain stimulation programming for parkinson\u2019s disease: the GUIDE Pilot study. Stereotact. Funct. Neurosurg. 93, 231\u2013239 (2015).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1015_CR144","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.wneu.2019.09.106","volume":"134","author":"N Pavese","year":"2020","unstructured":"Pavese, N., Tai, Y. F., Yousif, N., Nandi, D. & Bain, P. G. Traditional trial and error versus neuroanatomic 3-dimensional image software-assisted deep brain stimulation programming in patients with Parkinson disease. World Neurosurg. 134, e98\u2013e102 (2020).","journal-title":"World Neurosurg."},{"key":"1015_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.785529","volume":"12","author":"F Lange","year":"2021","unstructured":"Lange, F. et al. Reduced programming time and strong symptom control even in chronic course through imaging-based DBS programming. Front Neurol. 12, 785529 (2021).","journal-title":"Front Neurol."},{"key":"1015_CR146","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.brs.2021.07.064","volume":"14","author":"J Waldthaler","year":"2021","unstructured":"Waldthaler, J. et al. Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease. Brain Stimul. 14, 1109\u20131117 (2021).","journal-title":"Brain Stimul."},{"key":"1015_CR147","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/mds.28878","volume":"37","author":"J Roediger","year":"2022","unstructured":"Roediger, J. et al. StimFit-A data-driven algorithm for automated deep brain stimulation programming. Mov. Disord. 37, 574\u2013584 (2022).","journal-title":"Mov. Disord."},{"key":"1015_CR148","first-page":"3322","volume":"109","author":"F Meng","year":"2023","unstructured":"Meng, F. et al. Utilization, surgical populations, centers, coverages, regional balance, and their influential factors of deep brain stimulation for Parkinson\u2019s disease: a large-scale multicenter cross-sectional study from 1997 to 2021. Int J. Surg. 109, 3322\u20133336 (2023).","journal-title":"Int J. Surg."},{"key":"1015_CR149","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.parkreldis.2021.07.001","volume":"89","author":"VD Sharma","year":"2021","unstructured":"Sharma, V. D. et al. Telemedicine and deep brain stimulation\u2014current practices and recommendations. Parkinsonism Relat. Disord. 89, 199\u2013205 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1015_CR150","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/mds.27230","volume":"33","author":"O Jitkritsadakul","year":"2018","unstructured":"Jitkritsadakul, O., Rajalingam, R., Toenjes, C., Munhoz, R. P. & Fasano, A. Tele-health for patients with deep brain stimulation: The experience of the Ontario Telemedicine Network. Mov. Disord. 33, 491\u2013492 (2018).","journal-title":"Mov. Disord."},{"key":"1015_CR151","doi-asserted-by":"publisher","first-page":"e049955","DOI":"10.1136\/bmjopen-2021-049955","volume":"12","author":"S Marceglia","year":"2022","unstructured":"Marceglia, S. et al. Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson\u2019s disease. BMJ Open 12, e049955 (2022).","journal-title":"BMJ Open"},{"key":"1015_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105372","volume":"155","author":"Z Yin","year":"2021","unstructured":"Yin, Z. et al. Local field potentials in Parkinson\u2019s disease: a frequency-based review. Neurobiol. Dis. 155, 105372 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1015_CR153","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/brain\/awl103","volume":"129","author":"F Alonso-Frech","year":"2006","unstructured":"Alonso-Frech, F. et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson\u2019s disease. Brain 129, 1748\u20131757 (2006).","journal-title":"Brain"},{"key":"1015_CR154","doi-asserted-by":"crossref","unstructured":"Colombo A. et al. Finely tuned \u03b3 tracks medication cycles in Parkinson\u2019s disease: an ambulatory brain-sense study. Mov. Disord. (2025).","DOI":"10.1002\/mds.30160"},{"key":"1015_CR155","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1093\/brain\/awaa297","volume":"143","author":"M Muthuraman","year":"2020","unstructured":"Muthuraman, M. et al. Cross-frequency coupling between gamma oscillations and deep brain stimulation frequency in Parkinson\u2019s disease. Brain 143, 3393\u20133407 (2020).","journal-title":"Brain"},{"key":"1015_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1310393","volume":"17","author":"KB Wilkins","year":"2023","unstructured":"Wilkins, K. B., Melbourne, J. A., Akella, P. & Bronte-Stewart, H. M. Unraveling the complexities of programming neural adaptive deep brain stimulation in Parkinson\u2019s disease. Front. Hum. Neurosci. 17, 1310393 (2023).","journal-title":"Front. Hum. Neurosci."},{"key":"1015_CR157","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/mds.30076","volume":"40","author":"S Cernera","year":"2025","unstructured":"Cernera, S. et al. Sustained clinical benefit of adaptive deep brain stimulation in Parkinson\u2019s disease using gamma oscillations: a case report. Mov. Disord. 40, 345\u2013350 (2025).","journal-title":"Mov. Disord."},{"key":"1015_CR158","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1038\/s41591-024-03196-z","volume":"30","author":"CR Oehrn","year":"2024","unstructured":"Oehrn, C. R. et al. Chronic adaptive deep brain stimulation versus conventional stimulation in Parkinson\u2019s disease: a blinded randomized feasibility trial. Nat. Med. 30, 3345\u20133356 (2024).","journal-title":"Nat. Med."},{"key":"1015_CR159","doi-asserted-by":"publisher","first-page":"056026","DOI":"10.1088\/1741-2552\/abb416","volume":"17","author":"BI Ferleger","year":"2020","unstructured":"Ferleger, B. I. et al. Fully implanted adaptive deep brain stimulation in freely moving essential tremor patients. J. Neural Eng. 17, 056026 (2020).","journal-title":"J. Neural Eng."},{"key":"1015_CR160","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41531-024-00772-5","volume":"10","author":"S Stanslaski","year":"2024","unstructured":"Stanslaski, S. et al. Sensing data and methodology from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson\u2019s Disease (ADAPT-PD) clinical trial. NPJ Parkinsons Dis. 10, 174 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1015_CR161","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1136\/jnnp-2016-313518","volume":"87","author":"S Little","year":"2016","unstructured":"Little, S. et al. Adaptive deep brain stimulation for Parkinson\u2019s disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting. J. Neurol. Neurosurg. Psychiatry 87, 1388\u20131389 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1015_CR162","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/mds.26953","volume":"32","author":"M Rosa","year":"2017","unstructured":"Rosa, M. et al. Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients. Mov. Disord. 32, 628\u2013629 (2017).","journal-title":"Mov. Disord."},{"key":"1015_CR163","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ana.23951","volume":"74","author":"S Little","year":"2013","unstructured":"Little, S. et al. Adaptive deep brain stimulation in advanced Parkinson disease. Ann. Neurol. 74, 449\u2013457 (2013).","journal-title":"Ann. Neurol."},{"key":"1015_CR164","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/mds.26241","volume":"30","author":"M Rosa","year":"2015","unstructured":"Rosa, M. et al. Adaptive deep brain stimulation in a freely moving Parkinsonian patient. Mov. Disord. 30, 1003\u20131005 (2015).","journal-title":"Mov. Disord."},{"key":"1015_CR165","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/jnnp-2015-310972","volume":"87","author":"S Little","year":"2016","unstructured":"Little, S. et al. Bilateral adaptive deep brain stimulation is effective in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 87, 717\u2013721 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1015_CR166","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/mds.26959","volume":"32","author":"D Pi\u00f1a-Fuentes","year":"2017","unstructured":"Pi\u00f1a-Fuentes, D. et al. Adaptive DBS in a Parkinson\u2019s patient with chronically implanted DBS: a proof of principle. Mov. Disord. 32, 1253\u20131254 (2017).","journal-title":"Mov. Disord."},{"key":"1015_CR167","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/mds.27657","volume":"34","author":"M Arlotti","year":"2019","unstructured":"Arlotti, M. et al. Monitoring subthalamic oscillations for 24\u2009h in a freely moving Parkinson\u2019s disease patient. Mov. Disord. 34, 757\u2013759 (2019).","journal-title":"Mov. Disord."},{"key":"1015_CR168","doi-asserted-by":"publisher","first-page":"e971","DOI":"10.1212\/WNL.0000000000005121","volume":"90","author":"M Arlotti","year":"2018","unstructured":"Arlotti, M. et al. Eight-hours adaptive deep brain stimulation in patients with Parkinson disease. Neurology 90, e971\u2013e976 (2018).","journal-title":"Neurology"},{"key":"1015_CR169","doi-asserted-by":"publisher","first-page":"046006","DOI":"10.1088\/1741-2552\/aabc9b","volume":"15","author":"NC Swann","year":"2018","unstructured":"Swann, N. C. et al. Adaptive deep brain stimulation for Parkinson\u2019s disease using motor cortex sensing. J. Neural Eng. 15, 046006 (2018).","journal-title":"J. Neural Eng."},{"key":"1015_CR170","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.brs.2019.02.020","volume":"12","author":"A Velisar","year":"2019","unstructured":"Velisar, A. et al. Dual threshold neural closed loop deep brain stimulation in Parkinson disease patients. Brain Stimul. 12, 868\u2013876 (2019).","journal-title":"Brain Stimul."},{"key":"1015_CR171","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.brs.2020.06.018","volume":"13","author":"MN Petrucci","year":"2020","unstructured":"Petrucci, M. N. et al. Neural closed-loop deep brain stimulation for freezing of gait. Brain Stimul. 13, 1320\u20131322 (2020).","journal-title":"Brain Stimul."},{"key":"1015_CR172","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.brs.2020.07.016","volume":"13","author":"D Pi\u00f1a-Fuentes","year":"2020","unstructured":"Pi\u00f1a-Fuentes, D. et al. Acute effects of adaptive deep brain stimulation in Parkinson\u2019s disease. Brain Stimul. 13, 1507\u20131516 (2020).","journal-title":"Brain Stimul."},{"key":"1015_CR173","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41531-021-00229-z","volume":"7","author":"T Bocci","year":"2021","unstructured":"Bocci, T. et al. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease. NPJ Parkinsons Dis. 7, 88 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"1015_CR174","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41587-021-00897-5","volume":"39","author":"R Gilron","year":"2021","unstructured":"Gilron, R. et al. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson\u2019s disease. Nat. Biotechnol. 39, 1078\u20131085 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1015_CR175","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1093\/brain\/awad233","volume":"146","author":"S He","year":"2023","unstructured":"He, S. et al. Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson\u2019s disease. Brain 146, 5015\u20135030 (2023).","journal-title":"Brain"},{"key":"1015_CR176","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brs.2024.01.007","volume":"17","author":"JL Busch","year":"2024","unstructured":"Busch, J. L. et al. Single threshold adaptive deep brain stimulation in Parkinson\u2019s disease depends on parameter selection, movement state and controllability of subthalamic beta activity. Brain Stimul. 17, 125\u2013133 (2024).","journal-title":"Brain Stimul."},{"key":"1015_CR177","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clinph.2023.04.013","volume":"152","author":"L Alva","year":"2023","unstructured":"Alva, L. et al. Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation. Clin. Neurophysiol. 152, 43\u201356 (2023).","journal-title":"Clin. Neurophysiol."},{"key":"1015_CR178","unstructured":"Herrington, T. M. B. et al., H. Bronte-Stewart. Programming adaptive deep brain stimulation in the clinic: lessons from the ADAPT-PD Trial. Movement Disorders Society 2024."},{"key":"1015_CR179","unstructured":"Guidetti M. et al. Adaptive deep brain stimulation in Parkinson\u2019s disease: a Delphi consensus study. medRxiv 2024."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01015-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:03:19Z","timestamp":1751382199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01015-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01015-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.W.S. reports grant support from the NIH R01NS122943 as PI and Ro1 NS121120-01 as a Co-I. She reports past funding from Benign Essential Blepharospasm Research foundation, Dystonia coalition, Dystonia Medical Research foundation, National Organization for Rare Disorders. AWS has received consultant fees from Merz, Jazz and Acadia. She is the current Vice President for the Tremor Research Group and recent advisor for Supernus, Biogen-Sage and Encora. AWS and MM are currently serving as the associate editors for Nature Parkinson\u2019 disease journal.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}